Leadership Overview
Frontage Laboratories has 4 executives leading key functions including corporate strategy, operational efficiency, financial oversight, and scientific development.
Committed to accelerating drug discovery, Frontage Laboratories delivers integrated, science-driven product development services to global pharmaceutical and biotechnology partners, ensuring rigorous regulatory compliance and successful molecule advancement.
Committed to accelerating drug discovery, Frontage Laboratories delivers integrated, science-driven product development services to global pharmaceutical and biotechnology partners, ensuring rigorous regulatory compliance and successful molecule advancement.
Leadership Roles at Frontage Laboratories
Zhongping Lin - Co-Chief Executive Officer
Zhongping Lin, the Co-Chief Executive Officer at Frontage Laboratories, directs the overarching corporate strategy and long-term vision for the organization. By aligning internal research capabilities with the evolving needs of the global biotechnology sector, Lin ensures the company maintains a competitive edge in drug metabolism and pharmacokinetics. This leadership role involves constant collaboration with the Board to secure sustainable growth and market expansion across North America and Asia. Zhongping Lin monitors the integration of analytical testing and formulation development services to guarantee high-quality outcomes for pharmaceutical clients. Through the optimization of preclinical and clinical trial material manufacturing processes, the Co-Chief Executive Officer drives operational excellence. By fostering a culture of scientific rigor, Lin enables the firm to support complex molecule development cycles effectively. Ultimately, the Co-Chief Executive Officer secures the company's position as a premier partner for drug discovery and regulatory submission success.
Huan Wang - Interim Chief Financial Officer
Huan Wang, the Interim Chief Financial Officer at Frontage Laboratories, directs the financial planning, reporting, and capital allocation strategies for the organization. Overseeing the fiscal health of the company, the Interim Chief Financial Officer ensures that investments in laboratory technology and scientific talent align with long-term growth objectives. This role involves managing complex financial structures to support the expansion of clinical trial material manufacturing and bioanalysis services. Huan Wang monitors budgetary performance across all business units to maintain profitability while funding critical research initiatives. By providing data-driven insights to the executive team, the Interim Chief Financial Officer facilitates informed decision-making regarding market entry and service diversification. This leadership position requires rigorous oversight of financial compliance and risk management protocols. Through the optimization of capital resources, Wang secures the financial stability necessary for the firm to continue providing high-value, science-driven solutions to biotechnology and pharmaceutical partners worldwide.
Min Wang - Chief Operating Officer
Min Wang, the Chief Operating Officer at Frontage Laboratories, manages the daily execution of integrated service delivery across all laboratory facilities. Overseeing the infrastructure for bioanalysis and preclinical safety assessment, the Chief Operating Officer ensures that every project meets stringent quality standards and client timelines. This role requires constant coordination with department heads to streamline workflows and maximize resource allocation during the drug development process. Min Wang implements advanced operational protocols to enhance efficiency in toxicology assessments and early phase clinical studies. By refining internal systems, the Chief Operating Officer supports the company's mission to advance molecules through development stages with precision. This leadership position involves managing cross-functional teams to maintain high throughput in analytical testing. Through the continuous improvement of operational frameworks, Wang directly impacts the firm's ability to handle diverse client portfolios, ensuring that all laboratory operations remain scalable and responsive to international regulatory requirements.
Abdul Mutlib - Scientific Strategy Chief & Officer & President, Canada
Abdul Mutlib, the Scientific Strategy Chief & Officer & President, Canada at Frontage Laboratories, architects the technical roadmap and scientific innovation agenda for the entire organization. Overseeing the expansion of research capabilities in the Canadian market, the Scientific Strategy Chief & Officer & President, Canada ensures that all preclinical and clinical services remain at the forefront of industry standards. This role involves guiding the development of novel methodologies for drug metabolism and pharmacokinetics to address the unique challenges of modern drug discovery. Abdul Mutlib collaborates with global scientific teams to integrate advanced analytical testing into the broader service portfolio. By driving scientific excellence, the Scientific Strategy Chief & Officer & President, Canada enables the firm to support complex regulatory submissions across multiple international jurisdictions. This leadership position requires constant evaluation of emerging technologies to maintain the company's reputation for scientific integrity. Through strategic oversight, Mutlib ensures that all research initiatives directly contribute to the successful advancement of client molecules.
Explore Leadership Teams in Business Services
Founded in 1958 and headquartered in McLean, Virginia, The MITRE Corporation is a not-for-profit company providing engineering and technical guidance for the federal government.
Company Leadership SC

LF

Oak Ridge National Laboratory, founded in 1943 and headquartered in Oak Ridge, Tennessee, is an American multiprogram science and technology national laboratory sponsored by the U.S. Department of Energy (DOE) and administered, managed, and operated by UTBattelle as a federally funded research and development center (FFRDC) under a contract with the DOE.
Company Leadership JP

AP
Located in Burbank California, Micro Quality Labs specializes in providing Microbiological and Analytical testing services for the Cosmetic, Pharmaceutical, Nutritional and Food industries. The company's mission is to provide excellent customer service in addition to being efficient and reliable. The company is hands on and work closely with the company's clients to assure the company's mutual success. Micro Quality Labs was established in 2003 and is registered with the FDA, EPA and Health Canada. The company strictly adhere to cGMP standards and the company's equipment and instrumentation is state of the art. I am proud to announce that after more than a year of hard work, intense training and on-going audits, the company recently attained the company's ISO 17025 certification. ISO 17025 is an internationally recognized standard to measure laboratories on quality, management and technical requirements, and to recognize excellence in operations. This accreditation spotlights Micro Quality Labs commitment to delivering services of the best quality to its customers based on the highest internationally recognized practices and procedures. The company understands that trust is not given it is earned; At Micro Quality Labs, the company works hard everyday to earn your trust. The company knows that is not only the company's technical know-how that makes the company stand out but the company's people. The company has a great team that is highly trained and dedicated to working together to achieve the company's common goals. Please call the company today and experience the difference of the exceptional service of the team at Micro Quality Labs.
Company Leadership KT
JM
DC
SL
OFFICIAL PAGE - Renault Nissan Technology & Business Centre India (RNTBCI) is a captive automotive technology and business centre supporting Renault & Nissan globally. Established in 2007, it is located in Mahindra World City, Chennai, India, and the company's satellite offices are there in Hyderabad and Bengaluru. RNTBCI was bestowed with the ISO 9001:2015 certification in 2019 and ISO/IEC 27001:2013 certification in 2020 and is also now a Google Cloud Partner. RNTBCI contributes to Technology requirements with dedicated teams for Product Engineering: Vehicle and Components, Chassis, Powertrain, Embedded Software, Electrical and Electronic, Customer Performance, CAE and Test; Process Engineering: BIW, Trims, Stamping, Powertrain; Research and advanced Engineering: System Development, Battery Research, Social Research, and Creative Lab. RNTBCI has After-Sales Engineering, in-house Styling, and Test Capabilities for Multi-media/ EE Systems, Test Tracks, Test Chambers, and partnerships with various test agencies. RNTBCI also contributes to Business requirements in areas of IS/IT; APO; ACO and Global Shared Services (Finance, HR, GTC). As RNTBCI is serving both Renault and Nissan many of the Alliance practices are embodied in the company's way of working. RNTBCI is proud to be recognized by some of the important and influential organizations around the world. RNTBCI was felicitated as the ‘Best Employer of Tamil Nadu’ at the Tamil Nadu Best Employer Brand Awards 2022. For the fifth consecutive time, RNTBCI has been listed in the Top 100 Best Companies for Working Women by BCWI Study in 2022. RNTBCI has been commended time and again for CSR initiatives. The Indo-French Chamber of Commerce and Industry lauded RNTBCI’s CSR measures in 2021 and 2022. The Greater Chennai Corporation acknowledged and felicitated RNTBCI for CSR projects and support extended to the community during the COVID-19 pandemic.
Company Leadership CC
ST
PN
EA